SYN-100

N/A

Report date: 2025/03/25 14:45:49

Base Information

Drug NameSYN-100
Drug Alias NameRecombinant anti-Staphylococcus aureus toxin humanized monoclonal antibody้‡็ป„ๆŠ—้‡‘้ป„่‰ฒ่‘ก่„็ƒ่Œๆฏ’็ด ไบบๆบๅŒ–ๅ•ๅ…‹้š†ๆŠ—ไฝ“SYN 100SYN-100
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionBacterial toxin inhibitors
TargetsBacterial toxin
Therapy Area/IndicationsPneumonia, BacterialPneumonia, StaphylococcalStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSynermore Biologics (Suzhou) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSynermore Biologics (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsPneumonia, BacterialPneumonia, StaphylococcalStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A